Abstract
Compound Kushen Injection (CKI) is Sophora Flavescens and Heterosmilacis Japonicae extract. Meta-analysis confirmed that CKI plus transcatheter arterial chemoembolization (TACE) is more superior to TACE alone for unresectable hepatocellular carcinoma (UHCC) patients.
Keywords:
Compound Kushen Injection; TACE; Transcatheter arterial chemoembolization; hepatocellular carcinoma.
MeSH terms
-
Antineoplastic Agents, Phytogenic / therapeutic use*
-
Carcinoma, Hepatocellular / drug therapy
-
Carcinoma, Hepatocellular / therapy*
-
Chemoembolization, Therapeutic*
-
Drugs, Chinese Herbal / therapeutic use*
-
Humans
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / therapy*
-
Phytotherapy*
-
Sophora*
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Phytogenic
-
Drugs, Chinese Herbal
-
kushen